atricure
Whitney Tilson’s email to investors discussing Biden would create stronger economic growth and more jobs, economists find; Will We See a ‘Biden Bump’?; Kerrisdale short report on AtriCure.Q2 2020 hedge fund letters, conferences and moreBiden Would Create Stronger Economic Growth And More Jobs1) With the train wreck – oops, I mean first debate – behind us, all eyes are now on the election, which is only four weeks from Tuesday...As best I can tell, there's a widespread view in the business and investing community that a Biden win (62% likely according to PredictIt and 79% likely according to Fi...
ValueWalk
Kerrisdale Capital is short shares of AtriCure, Inc.Q2 2020 hedge fund letters, conferences and moreWe are short shares of AtriCure, a $1.9bn medical device company that manufactures and sells ablation equipment used in the surgical treatment of atrial fibrillation (AF). At about 7x forward revenues, AtriCure’s valuation implies that the company’s outlook is brighter than at any point in the last decade. But with the company’s core surgical ablation market almost completely saturated, and the relentless improvements in catheter ablation technology accelerating, AtriCure is facing both rapidly ...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら